Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes: the randomised, head-to-head CONCLUDE trial

AIMS/HYPOTHESIS: A head-to-head randomised trial was conducted to evaluate hypoglycaemia safety with insulin degludec 200 U/ml (degludec U200) and insulin glargine 300 U/ml (glargine U300) in individuals with type 2 diabetes treated with basal insulin. METHODS: This randomised (1:1), open-label, tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Philis-Tsimikas, Athena, Klonoff, David C., Khunti, Kamlesh, Bajaj, Harpreet S., Leiter, Lawrence A., Hansen, Melissa V., Troelsen, Lone N., Ladelund, Steen, Heller, Simon, Pieber, Thomas R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054369/
https://www.ncbi.nlm.nih.gov/pubmed/31984443
http://dx.doi.org/10.1007/s00125-019-05080-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054369/
https://www.ncbi.nlm.nih.gov/pubmed/31984443
http://dx.doi.org/10.1007/s00125-019-05080-9

Ejemplares similares